1. Pink Sheet
  2. >>Biosimilars & Generics
  3. >>Biosimilars

Can The Generics Industry Leverage Its COVID Success To Achieve Its Policy Goals?

 
• By Nielsen Hobbs

Vaccine makers get all the credit (among those who think any credit is due) for ending the pandemic, but generic sponsors want to remind policymakers that their plants stayed open during the worst of COVID-19 to ensure that hospitals were stocked and medicines for chronic conditions didn’t run short.

global leverage
HOW MUCH SWAY CAN THE GENERICS INDUSTRY EXERT on GLOBAL POLICIES? • Source: Shutterstock

The Association for Accessible Medicines’ annual meeting in Orlando transitioned into the International Generic and Biosimilar Medicines Association’s annual meeting midway through 15 February as the red, white and blue signage for AAM’s event was replaced with IGBA’s green color scheme and its oval-shaped world map logo.

The change in design elements was not accompanied by a shift in theme, however, as speakers continued to emphasize the incredible value that off-patent medicines provide to the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Biosimilars

More from Conferences